MIRA PHARMACEUTICALS, INC. - 8-K Filing
MIRA Pharmaceuticals reports new receptor selectivity findings for MIRA-55 showing 680-fold separation from mu opioid receptors. (Items: 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Other Exhibits)
Tickers: $MIRA